TY - JOUR AU - Kvien, T. K. PY - 2004 DA - 2004// TI - Epidemiology and burden of illness of rheumatoid arthritis JO - Pharmacoeconomics VL - 22 UR - https://doi.org/10.2165/00019053-200422001-00002 DO - 10.2165/00019053-200422001-00002 ID - Kvien2004 ER - TY - JOUR AU - Shaw, Y. AU - Bradley, M. AU - Dominique, A. AU - Michaud, K. AU - McDonald, D. AU - Simon, T. A. PY - 2018 DA - 2018// TI - Responding resiliently to chronic disease: rheumatoid arthritis patients’ discourse on coping strategies and challenges JO - Ann Rheum Dis VL - 77 ID - Shaw2018 ER - TY - JOUR AU - Shaw, Y. AU - Zhang, C. AU - Schumacher, R. AU - McDonald, D. AU - Simon, T. A. AU - Michaud, K. PY - 2018 DA - 2018// TI - Understanding the burden of rheumatoid arthritis using qualitative research: which impacts are not captured by patient-reported measures? JO - Ann Rheum Dis VL - 77 ID - Shaw2018 ER - TY - JOUR AU - Zhang, C. AU - Shaw, Y. AU - Shakley, B. AU - Ferri, L. AU - Michaud, K. AU - McDonald, D. PY - 2018 DA - 2018// TI - Understanding fatigue burden and coping strategies in rheumatoid arthritis using qualitative research JO - Ann Rheum Dis VL - 77 ID - Zhang2018 ER - TY - JOUR AU - Doran, M. F. AU - Crowson, C. S. AU - Pond, G. R. AU - O’Fallon, W. M. AU - Gabriel, S. E. PY - 2002 DA - 2002// TI - Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study JO - Arthritis Rheum VL - 46 UR - https://doi.org/10.1002/art.10524 DO - 10.1002/art.10524 ID - Doran2002 ER - TY - JOUR AU - Smitten, A. L. AU - Choi, H. K. AU - Hochberg, M. C. AU - Suissa, S. AU - Simon, T. A. AU - Testa, M. A. PY - 2008 DA - 2008// TI - The risk of hospitalized infection in patients with rheumatoid arthritis JO - J Rheumatol VL - 35 ID - Smitten2008 ER - TY - JOUR AU - Smitten, A. L. AU - Simon, T. A. AU - Hochberg, M. C. AU - Suissa, S. PY - 2008 DA - 2008// TI - A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis JO - Arthritis Res Ther VL - 10 UR - https://doi.org/10.1186/ar2404 DO - 10.1186/ar2404 ID - Smitten2008 ER - TY - JOUR AU - Simon, T. A. AU - Thompson, A. AU - Gandhi, K. K. AU - Hochberg, M. AU - Suissa, S. PY - 2015 DA - 2015// TI - Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis JO - Arthritis Res Ther. VL - 17 UR - https://doi.org/10.1186/s13075-015-0728-9 DO - 10.1186/s13075-015-0728-9 ID - Simon2015 ER - TY - JOUR AU - Zintzaras, E. AU - Voulgarelis, M. AU - Moutsopoulos, H. M. PY - 2005 DA - 2005// TI - The risk of lymphoma development in autoimmune diseases: a meta-analysis JO - Arch Intern Med VL - 165 UR - https://doi.org/10.1001/archinte.165.20.2337 DO - 10.1001/archinte.165.20.2337 ID - Zintzaras2005 ER - TY - JOUR AU - Bongartz, T. AU - Sutton, A. J. AU - Sweeting, M. J. AU - Buchan, I. AU - Matteson, E. L. AU - Montori, V. PY - 2006 DA - 2006// TI - Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials JO - JAMA VL - 295 UR - https://doi.org/10.1001/jama.295.19.2275 DO - 10.1001/jama.295.19.2275 ID - Bongartz2006 ER - TY - JOUR AU - Listing, J. AU - Strangfeld, A. AU - Kary, S. AU - Rau, R. AU - Hinueber, U. AU - Stoyanova-Scholz, M. PY - 2005 DA - 2005// TI - Infections in patients with rheumatoid arthritis treated with biologic agents JO - Arthritis Rheum VL - 52 UR - https://doi.org/10.1002/art.21386 DO - 10.1002/art.21386 ID - Listing2005 ER - TY - JOUR AU - Leombruno, J. P. AU - Einarson, T. R. AU - Keystone, E. C. PY - 2009 DA - 2009// TI - The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events JO - Ann Rheum Dis VL - 68 UR - https://doi.org/10.1136/ard.2008.091025 DO - 10.1136/ard.2008.091025 ID - Leombruno2009 ER - TY - JOUR AU - Schneeweiss, S. AU - Setoguchi, S. AU - Weinblatt, M. E. AU - Katz, J. N. AU - Avorn, J. AU - Sax, P. E. PY - 2007 DA - 2007// TI - Anti-tumor necrosis factor alpha therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis JO - Arthritis Rheum VL - 56 UR - https://doi.org/10.1002/art.22600 DO - 10.1002/art.22600 ID - Schneeweiss2007 ER - TY - JOUR AU - Simon, T. A. AU - Askling, J. AU - Lacaille, D. AU - Franklin, J. AU - Wolfe, F. AU - Covucci, A. PY - 2010 DA - 2010// TI - Infections requiring hospitalization in the abatacept clinical development program: an epidemiological assessment JO - Arthritis Res Ther VL - 12 UR - https://doi.org/10.1186/ar2984 DO - 10.1186/ar2984 ID - Simon2010 ER - TY - JOUR AU - Solomon, D. H. AU - Lunt, M. AU - Schneeweiss, S. PY - 2008 DA - 2008// TI - The risk of infection associated with tumor necrosis factor alpha antagonists: making sense of epidemiologic evidence JO - Arthritis Rheum VL - 58 UR - https://doi.org/10.1002/art.23396 DO - 10.1002/art.23396 ID - Solomon2008 ER - TY - JOUR AU - Askling, J. AU - Fahrbach, K. AU - Nordstrom, B. AU - Ross, S. AU - Schmid, C. H. AU - Symmons, D. PY - 2011 DA - 2011// TI - Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data JO - Pharmacoepidermiol Drug Saf VL - 20 UR - https://doi.org/10.1002/pds.2046 DO - 10.1002/pds.2046 ID - Askling2011 ER - TY - JOUR AU - Schiff, M. AU - Weinblatt, M. E. AU - Valente, R. AU - Heijde, D. AU - Citera, G. AU - Elegbe, A. PY - 2014 DA - 2014// TI - Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial JO - Ann Rheum Dis VL - 73 UR - https://doi.org/10.1136/annrheumdis-2013-203843 DO - 10.1136/annrheumdis-2013-203843 ID - Schiff2014 ER - TY - JOUR AU - Ramiro, S. AU - Sepriano, A. AU - Chatzidionysiou, K. AU - Nam, J. L. AU - Smolen, J. S. AU - Heijde, D. PY - 2017 DA - 2017// TI - Safety of synthetic and biological DMARDs: a systematic literature review informing the 2016 update of the EULAR recommendations for management of rheumatoid arthritis JO - Ann Rheum Dis VL - 76 UR - https://doi.org/10.1136/annrheumdis-2016-210708 DO - 10.1136/annrheumdis-2016-210708 ID - Ramiro2017 ER - TY - JOUR AU - Bedi, B. AU - Li, J. Y. AU - Grassi, F. AU - Tawfeek, H. AU - Weitzmann, M. N. AU - Pacifici, R. PY - 2010 DA - 2010// TI - Inhibition of antigen presentation and T cell costimulation blocks PTH-induced bone loss JO - Ann N Y Acad Sci VL - 1192 UR - https://doi.org/10.1111/j.1749-6632.2009.05216.x DO - 10.1111/j.1749-6632.2009.05216.x ID - Bedi2010 ER - TY - JOUR AU - Bingham, C. O. PY - 2008 DA - 2008// TI - Emerging therapeutics for rheumatoid arthritis JO - Bull NYU Hosp Jt Dis VL - 66 ID - Bingham2008 ER - TY - JOUR AU - Cutolo, M. AU - Nadler, S. PY - 2013 DA - 2013// TI - Advances in CTLA-4-Ig-mediated modulation of inflammatory cell and immune response activation in rheumatoid arthritis JO - Autoimmun Rev VL - 12 UR - https://doi.org/10.1016/j.autrev.2013.01.001 DO - 10.1016/j.autrev.2013.01.001 ID - Cutolo2013 ER - TY - JOUR AU - Davis, P. M. AU - Nadler, S. G. AU - Stetsko, D. K. AU - Suchard, S. J. PY - 2008 DA - 2008// TI - Abatacept modulates human dendritic cell-stimulated T-cell proliferation and effector function independent of IDO induction JO - Clin Immunol VL - 126 UR - https://doi.org/10.1016/j.clim.2007.08.019 DO - 10.1016/j.clim.2007.08.019 ID - Davis2008 ER - TY - JOUR AU - Alten, R. AU - Kaine, J. AU - Keystone, E. AU - Nash, P. AU - Delaet, I. AU - Qi, K. PY - 2012 DA - 2012// TI - Safety of SC abatacept in patients with RA: update from pooled clinical trial data JO - Ann Rheum Dis VL - 71 ID - Alten2012 ER - TY - JOUR AU - Alten, R. AU - Kaine, J. AU - Keystone, E. C. AU - Nash, P. AU - Delaet, I. AU - Qi, K. PY - 2011 DA - 2011// TI - Safety of subcutaneous abatacept in patients with rheumatoid arthritis (RA): integrated analysis of five clinical trials up to 4.5 years JO - Ann Rheum Dis VL - 70 ID - Alten2011 ER - TY - JOUR AU - Becker, J. C. AU - Westhovens, R. AU - Hochberg, M. AU - Qi, K. AU - Kelly, S. AU - Smitten, A. PY - 2010 DA - 2010// TI - The long-term safety of abatacept in the treatment of rheumatoid arthritis: integrated analyses from the abatacept clinical trial program JO - Ann Rheum Dis VL - 69 ID - Becker2010 ER - TY - JOUR AU - Escudero Contreras, A. AU - Castro-Villegas, M. C. AU - Hernández-Hernández, M. V. AU - Díaz-González, F. PY - 2011 DA - 2011// TI - Efficacy and safety of abatacept in patients with rheumatoid arthritis and no prior treatment with biologics JO - Reumatol Clin VL - 7 UR - https://doi.org/10.1016/j.reuma.2011.06.007 DO - 10.1016/j.reuma.2011.06.007 ID - Escudero Contreras2011 ER - TY - JOUR AU - Alten, R. AU - Kaine, J. AU - Keystone, E. AU - Nash, P. AU - Delaet, I. AU - Genovese, M. C. PY - 2014 DA - 2014// TI - Long-term safety of subcutaneous abatacept in rheumatoid arthritis: integrated analysis of clinical trial data representing more than four years of treatment JO - Arthritis Rheumatol VL - 66 UR - https://doi.org/10.1002/art.38687 DO - 10.1002/art.38687 ID - Alten2014 ER - TY - JOUR AU - Simon, T. A. AU - Smitten, A. L. AU - Franklin, J. AU - Askling, J. AU - Lacaille, D. AU - Wolfe, F. PY - 2009 DA - 2009// TI - Malignancies in the rheumatoid arthritis abatacept clinical development programme: an epidemiological assessment JO - Ann Rheum Dis VL - 68 UR - https://doi.org/10.1136/ard.2008.097527 DO - 10.1136/ard.2008.097527 ID - Simon2009 ER - TY - JOUR AU - MacLean, C. H. AU - Park, G. S. AU - Traina, S. B. AU - Liu, H. H. AU - Hahn, B. H. AU - Paulus, H. E. PY - 2001 DA - 2001// TI - Positive predictive value (PPV) of an administrative data-based algorithm for the identification of patients with rheumatoid arthritis (RA) JO - Arthritis Rheum VL - 44 ID - MacLean2001 ER - TY - JOUR AU - Calderwood, M. S. AU - Platt, R. AU - Hou, X. AU - Malenfant, J. AU - Haney, G. AU - Kruskal, B. PY - 2010 DA - 2010// TI - Real-time surveillance for tuberculosis using electronic health record data from an ambulatory practice in eastern Massachusetts JO - Public Health Rep VL - 125 UR - https://doi.org/10.1177/003335491012500611 DO - 10.1177/003335491012500611 ID - Calderwood2010 ER - TY - STD TI - Berlin JA. The use of meta-analysis in pharmacoepidemiology. In: Strom BL, editor. Pharmacoepidemiology. 3rd Editon ed. West Sussex: Wiley; 2000. p. 633–659. ID - ref31 ER - TY - JOUR AU - DerSimonian, R. AU - Laird, N. PY - 1986 DA - 1986// TI - Meta-analysis in clinical trials JO - Control Clin Trials VL - 7 UR - https://doi.org/10.1016/0197-2456(86)90046-2 DO - 10.1016/0197-2456(86)90046-2 ID - DerSimonian1986 ER - TY - JOUR AU - Higgins, J. P. AU - Thompson, S. G. PY - 2002 DA - 2002// TI - Quantifying heterogeneity in a meta-analysis JO - Stat Med VL - 21 UR - https://doi.org/10.1002/sim.1186 DO - 10.1002/sim.1186 ID - Higgins2002 ER - TY - JOUR AU - Kim, S. e. o. y. o. u. n. g. C. AU - Pawar, A. j. i. n. k. y. a. AU - Desai, R. i. s. h. i. J. AU - Solomon, D. a. n. i. e. l. H. AU - Gale, S. a. r. a. AU - Bao, M. i. n. AU - Sarsour, K. h. a. l. e. d. AU - Schneeweiss, S. e. b. a. s. t. i. a. n. PY - 2019 DA - 2019// TI - Risk of malignancy associated with use of tocilizumab versus other biologics in patients with rheumatoid arthritis: A multi-database cohort study JO - Seminars in Arthritis and Rheumatism VL - 49 UR - https://doi.org/10.1016/j.semarthrit.2019.03.002 DO - 10.1016/j.semarthrit.2019.03.002 ID - Kim2019 ER - TY - JOUR AU - Montastruc, F. AU - Renoux, C. AU - Dell’Aniello, S. AU - Simon, T. A. AU - Azoulay, L. AU - Hudson, M. PY - 2019 DA - 2019// TI - Abatacept initiation in rheumatoid arthritis and the risk of cancer: a population-based comparative cohort study JO - Rheumatology VL - 58 UR - https://doi.org/10.1093/rheumatology/key352 DO - 10.1093/rheumatology/key352 ID - Montastruc2019 ER - TY - JOUR AU - Lopez-Olivo, M. A. AU - Tayar, J. H. AU - Martinez-Lopez, J. A. AU - Pollono, E. N. AU - Cueto, J. P. AU - Gonzales-Crespo, M. R. PY - 2012 DA - 2012// TI - Risk of malignancies in patients with rheumatoid arthritis treated with biologic therapy: a meta-analysis JO - JAMA VL - 308 UR - https://doi.org/10.1001/2012.jama.10857 DO - 10.1001/2012.jama.10857 ID - Lopez-Olivo2012 ER - TY - JOUR AU - Wadström, H. AU - Frisell, T. AU - Askling, J. PY - 2017 DA - 2017// TI - Malignant neoplasms in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors, tocilizumab, abatacept, or rituximab in clinical practice: a nationwide cohort study from Sweden JO - JAMA Intern Med VL - 177 UR - https://doi.org/10.1001/jamainternmed.2017.4332 DO - 10.1001/jamainternmed.2017.4332 ID - Wadström2017 ER - TY - JOUR AU - Herrero-Beaumont, G. AU - Martinez Calatrava, M. J. AU - Castaneda, S. PY - 2012 DA - 2012// TI - Abatacept mechanism of action: concordance with its clinical profile JO - Reumatol Clin VL - 8 UR - https://doi.org/10.1016/j.reuma.2011.08.002 DO - 10.1016/j.reuma.2011.08.002 ID - Herrero-Beaumont2012 ER - TY - JOUR AU - Suissa, S. AU - Moodie, E. E. AU - Dell’Aniello, S. PY - 2017 DA - 2017// TI - Prevalent new-user cohort designs for comparative drug effect studies by time-conditional propensity scores JO - Pharmacoepidermiol Drug Saf VL - 26 UR - https://doi.org/10.1002/pds.4107 DO - 10.1002/pds.4107 ID - Suissa2017 ER - TY - JOUR AU - Greenberg, J. D. AU - Reed, G. AU - Kremer, J. M. AU - Tindall, E. AU - Kavanaugh, A. AU - Zheng, C. PY - 2010 DA - 2010// TI - Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry JO - Ann Rheum Dis VL - 69 UR - https://doi.org/10.1136/ard.2008.089276 DO - 10.1136/ard.2008.089276 ID - Greenberg2010 ER - TY - JOUR AU - Nam, J. L. AU - Winthrop, K. L. AU - Vollenhoven, R. F. AU - Pavelka, K. AU - Valesini, G. AU - Hensor, E. M. PY - 2010 DA - 2010// TI - Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA JO - Ann Rheum Dis VL - 69 UR - https://doi.org/10.1136/ard.2009.126573 DO - 10.1136/ard.2009.126573 ID - Nam2010 ER - TY - JOUR AU - Dixon, W. G. AU - Watson, K. AU - Lunt, M. AU - Hyrich, K. L. AU - Silman, A. J. AU - Symmons, D. P. PY - 2006 DA - 2006// TI - Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register JO - Arthritis Rheum VL - 54 UR - https://doi.org/10.1002/art.21978 DO - 10.1002/art.21978 ID - Dixon2006 ER - TY - JOUR AU - Mori, S. AU - Yoshitama, T. AU - Hidaka, T. AU - Sakai, F. AU - Hasegawa, M. AU - Hashiba, Y. PY - 2017 DA - 2017// TI - Comparative risk of hospitalized infection between biological agents in rheumatoid arthritis patients: a multicenter retrospective cohort study in Japan JO - PLoS One VL - 12 UR - https://doi.org/10.1371/journal.pone.0179179 DO - 10.1371/journal.pone.0179179 ID - Mori2017 ER - TY - JOUR AU - Barber, C. AU - Lacaille, D. AU - Fortin, P. R. PY - 2013 DA - 2013// TI - Systematic review of validation studies of the use of administrative data to identify serious infections JO - Arthritis Care Res VL - 65 UR - https://doi.org/10.1002/acr.21959 DO - 10.1002/acr.21959 ID - Barber2013 ER - TY - JOUR AU - Cantini, F. AU - Niccoli, L. AU - Goletti, D. PY - 2014 DA - 2014// TI - Tuberculosis risk in patients treated with non-anti-tumor necrosis factor-α (TNF-α) targeted biologics and recently licensed TNF-α inhibitors: data from clinical trials and national registries JO - J Rheumatol Suppl VL - 91 UR - https://doi.org/10.3899/jrheum.140103 DO - 10.3899/jrheum.140103 ID - Cantini2014 ER -